Acacia Pharma

Funds to be Used to Complete Two Phase II Programmes

Older News

CAMBRIDGE, England, March 31, 2011 - Acacia Pharma, a pharmaceutical company specialising in the development of drugs for cancer supportive care, announces it has successfully closed a funding round, raising a total of $10 million.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy